Intermittent short courses of cyclosporine microemulsion for the long-term management of psoriasis: A 2-year cohort study

Journal of the American Academy of Dermatology

Volumn 44, Issue 4, 2001, Pages 643-651

  Ho, Vincent C Y ^{a,b,c,d,e,f,g,h,i}   Griffiths, Christopher E M ^{a,b,c,d,e,f,g,h,i}   Berth Jones, John ^{a,b,c,d,e,f,g,h,i}   Papp, Kim A ^{a,b,c,d,e,f,g,h,i}   Vanaclocha, Francisco ^{a,b,c,d,e,f,g,h,i}   Dauden, Esteban ^{a,b,c,d,e,f,g,h,i}   Beard, Anna ^{a,b,c,d,e,f,g,h,i}   Puvanarajan, Lohita ^{a,b,c,d,e,f,g,h,i}   Paul, Carle ^{a,b,c,d,e,f,g,h,i}  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b HOPE HOSPITAL   (United Kingdom)

^c WALSGRAVE HOSPITAL   (United Kingdom)

^d St Mary's General Hospital   (Belgium)

^e HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^f HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^g Novartis UK Pharmaceuticals Ltd   (United Kingdom)

^h Hartington Statistics and Data Management Ltd   (United Kingdom)

ⁱ NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; CYCLOSPORIN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; FEMALE; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MICROEMULSION; MULTICENTER STUDY; NEPHROTOXICITY; PRIORITY JOURNAL; PSORIASIS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL;

EID: 0035094870     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1067/mjd.2001.112400     Document Type: Article

References (16)

1. Psoriasis
2. The effect of severe psoriasis on the quality of life of 369 patients
3. Biological effects of cyclosporin A: A new antilymphocytic agent
4. Cyclosporin: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic uses in immunoregulatory disorders
5. Cyclosporin A for psoriasis
6. Cyclosporine consensus conference: With emphasis on the treatment of psoriasis
7. Renal biopsy findings in long-term cyclosporin treatment of psoriasis
8. Duration of remission during maintenance cyclosporine therapy for psoriasis: Relationship to maintenance dose and degree of improvement during initial therapy
9. Cyclosporine as maintenance therapy in patients with severe psoriasis
10. A randomized double-blind study comparing the efficacy, safety and optimal dose of two formulations of cyclosporin, Neoral and Sandimmun, in patients with severe psoriasis: The OLP302 Study Group
11. Intermittent short courses of cyclosporin (Neoral®) for psoriasis unresponsive to topical therapy: A 1-year multicentre, randomized study
12. Treatment of psoriasis with intermittent short course cyclosporin (Neopral®): A multicentre study
13. Consensus conference on cyclosporin A microemulsion for psoriasis, June 1996
14. Severe psoriasis - Oral therapy with a new retinoid
15. Dermatology Life Quality Index (DLQI): A simple practical measure for routine clinical use
16. Long-term safety of cyclosporine in the treatment of psoriasis